WHO SHOULD TAKE DIDANOSINE?
Didanosine was approved in 1991 as an antiretroviral drug (ARV) for people with HIV infection. The generic version was approved in 2004. It has been studied in adults and children who weigh at 20 kg (44 lbs). There are no absolute rules about when to start ART. You and your health care provider should consider your CD4 cell count, your viral load, any symptoms you are having, and your attitude about taking ART. Fact Sheet 404 has more information about guidelines for the use of ART. If you take didanosine with other ARVs, you can reduce your viral load to extremely low levels, and increase your CD4 cell counts. This should mean staying healthier longer.
